以生物医药为匙打开全球最大“隐形市场”——四川服务贸易成果加速上“新”

每日经济新闻
27 Dec 2024

近年来,四川省生物医药产业诞生的知识产权国际授权交易不断刷新创新药License-out(许可输出,即中国创新药对外授权许可)的金额新高。  统计数据显示,2023年四川省医药健康产业实现营业收入近6000亿元,而仅以科伦博泰、百利天恒等五家医药企业的知识产权国际授权交易计算,其潜在交易总额就超200亿美元。这些授权交易,不仅为新药企业拿回了宝贵的研发资金,还验证了“川籍”药企的创新实力。  作为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10